SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-008129
Filing Date
2016-02-25
Accepted
2016-02-25 08:43:22
Documents
17
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20--F f20f_022516.htm 20-F 1589953
2 EXHIBIT 1.1 exh_11.htm EX-1.1 217095
3 EXHIBIT 4.7 exh_47.htm EX-4.7 129397
4 EXHIBIT 4.9 exh_49.htm EX-4.9 18883
5 EXHIBIT 4.12 exh_412.htm EX-4.12 9924
6 EXHIBIT 4.13 exh_413.htm EX-4.13 136656
7 EXHIBIT 4.19 exh_419.htm EX-4 8779
8 EXHIBIT 4.21 exh_421.htm EX-4.21 1116931
9 EXHIBIT 4.22 exh_422.htm EX-4.22 10758
10 EXHIBIT 12.1 exh_121.htm EX-12.1 10300
11 EXHIBIT 12.2 exh_122.htm EX-12.2 10491
12 EXHIBIT 13 exh_13.htm EX-13 4007
13 EXHIBIT 15.1 exh_151.htm EX-15.1 3983
14 GRAPHIC quintileslogo.jpg GRAPHIC 30076
15 GRAPHIC questlogo.jpg GRAPHIC 35986
16 GRAPHIC pwc.jpg GRAPHIC 2216
17 GRAPHIC pdf.jpg GRAPHIC 10052
  Complete submission text file 0001171843-16-008129.txt   3370944
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-35773 | Film No.: 161454053
SIC: 2834 Pharmaceutical Preparations